SECAUCUS, N.J., Aug. 14,
2024 /PRNewswire/ -- Quest Diagnostics (NYSE:
DGX), a leader in diagnostic information services, today announced
that its Board of Directors declared a quarterly cash dividend
of $0.75 per share, payable on October 21,
2024 to shareholders of record of Quest Diagnostics
common stock on October 4, 2024.
![Quest Diagnostics Incorporated logo. (PRNewsFoto/Quest Diagnostics Incorporated) Quest Diagnostics Incorporated logo. (PRNewsFoto/Quest Diagnostics Incorporated)](https://mma.prnewswire.com/media/200883/quest_diagnostics_incorporated_logo_logo.jpg)
About Quest Diagnostics
Quest Diagnostics works across
the healthcare ecosystem to create a healthier world, one life at a
time. We provide diagnostic insights from the results of our
laboratory testing to empower people, physicians and organizations
to take action to improve health outcomes. Derived from the world's
largest database of de-identifiable clinical lab results, Quest's
diagnostic insights reveal new avenues to identify and treat
disease, inspire healthy behaviors and improve healthcare
management. Quest Diagnostics annually serves one in three adult
Americans and half the physicians and hospitals in the
United States, and our nearly
50,000 employees understand that, in the right hands and with the
right context, our diagnostic insights can inspire actions that
transform lives and create a healthier
world. www.QuestDiagnostics.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-302222903.html
SOURCE Quest Diagnostics